• 1
    Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 15560.
  • 2
    Briët E, Van Der Meer FJ, Rosendaal FR, Houwing-Duistermaat JJ, Van Houwelingen HC. The family history and inherited thrombophilia. Br J Haematol 1994; 87: 34852.
  • 3
    Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction Semin Hematol 1997; 34: 17187.
  • 4
    Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 80915.DOI: 10.1001/archinte.160.6.809
  • 5
    Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 341520.DOI: 10.1001/archinte.160.22.3415
  • 6
    Ambrus JL, Ambrus CM, Mink IB, Pickren JW. Causes of death in cancer patients. J Med 1975; 6: 614.
  • 7
    Gale AJ, Gordon SG. Update on tumor cell procoagulant factors. Acta Haematol 2001; 106: 2532.DOI: 10.1159/000046586
  • 8
    Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 2001; 106: 1824.DOI: 10.1159/000046585
  • 9
    Trousseau A. Phlegmasia Alba Dolens. Lectures on Clinical Medicine. London: The New Sydenham Society. 1868; 5: 281331.
  • 10
    Sproul EE. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938; 34: 56673.
  • 11
    Thompson CM, Rodgers LR. Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism. Am J Med Sci 1952; 223: 952.
  • 12
    Mikal S, Campbell AJA. Carcinoma of the pancreas. Diagnostic and operative criteria based on one hundred consecutive autopsies. Surgery 1950; 28: 9639.
  • 13
    Miller JR, Baggenstoss AH, Comfort MW. Carcinoma of the pancreas. Effect of histological type and grade of malignancy on its behaviour. Cancer 1951; 4: 23341.
  • 14
    Monreal M, Fernandez-Llamazares J, Perandreu J, Urrutia A, Sahuquillo JC, Contel E. Occult cancer in patients with venous thromboembolism: which patients, which cancers. Thromb Haemost 1997; 78: 13168.
  • 15
    Sørensen HT, Mellemkjær L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 116973.
  • 16
    Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 107780.
  • 17
    SIG Zorginformatie, Landelijke Medische Registratie (LMR), (SIG Health Care Information, National Medical Registration). Tables on hospital admissions, 1992–1994. (address: Maliebaan 50, P.O. Box 14066, 3508 SC Utrecht). Utrecht 1996.
  • 18
    Rassam JW, Anderson G. Incidence of paramalignant disorders in bronchogenic carcinoma. Thorax 1975; 30: 8690.
  • 19
    Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin–mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 2003; 112: 85362.
  • 20
    Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P, Girolami A. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994; 154: 1648.
  • 21
    Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 1999; 78: 28591.
  • 22
    Lauderdale DS, Furner SE, Miles TP, Goldberg J. Epidemiologic uses of Medicare data. Epidemiol Rev 1993; 15: 31927.
  • 23
    Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, De Pauw S. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1988; 318: 4047.
  • 24
    Graf AH, Graf B, Brandis MG, Kogelnik HD, Staudach A, Traun H. Oral Anticoagulation in patients with gynecological cancer and radiotherapy: a retrospective analysis of 132 patients. Anticancer Res 1998; 18: 204751.
  • 25
    Palareti G, Legnani C, Lee A, Manotti C, Hirsh J, D'Angelo A, Pengo V, Moia M, Coccheri S. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Thromb Haemost 2000; 84: 80510.
  • 26
    Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 2000; 18: 307883.